-
1
المؤلفون: Jose Lopez-Sendon, Maurizio Averna, Daniel Gaudet, Alexia Letierce, Maciej Banach, Patrick Henry, Megan Loy, Isabela Batsu, Gregory Bigot, Garen Manvelian, Rita Samuel
المصدر: European Journal of Preventive Cardiology. 28:1864-1872
مصطلحات موضوعية: Adult, Male, myalgia, Canada, medicine.medical_specialty, Statin, Epidemiology, medicine.drug_class, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, Real life setting, 03 medical and health sciences, 0302 clinical medicine, Dose adjustment, Internal medicine, medicine, Humans, In patient, Prospective Studies, 030212 general & internal medicine, Adverse effect, Aged, Alirocumab, business.industry, Incidence (epidemiology), Middle Aged, Treatment Outcome, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87073ffd1dc9968fd83c5218d4ca9b7Test
https://doi.org/10.1093/eurjpc/zwaa097Test -
2
المؤلفون: Lawrence A. Leiter, Kausik K. Ray, Antonio J. Vallejo-Vaz, Rita Samuel, Jonas Mandel, Alexia Letierce, Maja Bujas-Bobanovic, Dirk Müller-Wieland, Stefano Del Prato, Marja-Riitta Taskinen
المساهمون: Universidad de Sevilla. Departamento de Medicina, Regeneron Pharmaceuticals, Inc., Sanofi
المصدر: European Journal of Preventive Cardiology
مصطلحات موضوعية: Male, Cardiac & Cardiovascular Systems, Epidemiology, 030204 cardiovascular system & hematology, NON-HDL CHOLESTEROL, Full Research Paper, DISEASE, HYPERCHOLESTEROLEMIA, chemistry.chemical_compound, 0302 clinical medicine, non-high-density lipoprotein cholesterol, 030212 general & internal medicine, Lipoprotein cholesterol, proprotein convertase subtilisin, 2. Zero hunger, Alirocumab, goal attainment, low-density lipoprotein cholesterol, proprotein convertase subtilisin/kexin type 9, triglycerides, Middle Aged, REMNANT CHOLESTEROL, Non-high-density lipoprotein cholesterol, Treatment Outcome, Cardiovascular Diseases, SAFETY, lipids (amino acids, peptides, and proteins), Female, Seasons, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, kexin type 9, Goals, medicine.drug, medicine.medical_specialty, EZETIMIBE, Proprotein convertase subtilisin/kexin type 9, Antibodies, Monoclonal, Humanized, RESIDUAL RISK, 03 medical and health sciences, Ezetimibe, Internal medicine, medicine, Humans, Low-density lipoprotein cholesterol, Triglycerides, Science & Technology, Triglyceride, Dose-Response Relationship, Drug, business.industry, CARDIOVASCULAR-RISK PATIENTS, Non high density lipoprotein cholesterol, Cholesterol, LDL, EFFICACY, Goal attainment, Residual risk, Endocrinology, chemistry, INHIBITOR ALIROCUMAB, Cardiovascular System & Cardiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Biomarkers, Lipoprotein
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec8c6fd395b5c478da5449379641bf48Test
https://pubmed.ncbi.nlm.nih.gov/32188296Test -
3
المؤلفون: Catherine Domenger, Stefano Del Prato, Helen M. Colhoun, Bertrand Cariou, Marc Israel, Kausik K. Ray, Rita Samuel, Alexia Letierce, Francisco J. Tinahones, Dirk Müller-Wieland, Lawrence A. Leiter
المصدر: Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-11 (2020)
Cardiovascular Diabetology
Cardiovascular diabetology 19, 14 (2020). doi:10.1186/s12933-020-0991-1
Colhoun, H M, Leiter, L A, Müller-Wieland, D, Cariou, B, Ray, K K, Tinahones, F J, Domenger, C, Letierce, A, Israel, M, Samuel, R & Del Prato, S 2020, ' Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol ', Cardiovascular diabetology, vol. 19, no. 1, pp. 14 . https://doi.org/10.1186/s12933-020-0991-1Testمصطلحات موضوعية: Non-HDL-C, Male, lcsh:Diseases of the circulatory (Cardiovascular) system, Cardiac & Cardiovascular Systems, Time Factors, Apolipoprotein B, Endocrinology, Diabetes and Metabolism, RATIONALE, Type 2 diabetes, Gastroenterology, PCSK9, Diabetes mellitus, DESIGN, Monoclonal, 1102 Cardiorespiratory Medicine and Haematology, Humanized, Original Investigation, RISK, Fenofibrate, biology, Anticholesteremic Agents, PCSK9 Inhibitors, Usual care, ASSOCIATION, Middle Aged, Cholesterol, Treatment Outcome, SAFETY, lipids (amino acids, peptides, and proteins), Female, ODYSSEY, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, INTERVENTION, Type 2, medicine.drug, medicine.medical_specialty, Statin, HDL, medicine.drug_class, Antibodies, Monoclonal, Humanized, Antibodies, POOLED ANALYSIS, Endocrinology & Metabolism, Ezetimibe, Internal medicine, MANAGEMENT, medicine, Humans, Alirocumab, DM-DYSLIPIDEMIA, HDL-C, Triglycerides, Aged, Biomarkers, Cholesterol, HDL, Diabetes Mellitus, Type 2, Dyslipidemias, Protease Inhibitors, ddc:610, ESC/EAS GUIDELINES, Science & Technology, business.industry, nutritional and metabolic diseases, medicine.disease, REDUCTION, Cardiovascular System & Hematology, lcsh:RC666-701, Cardiovascular System & Cardiology, biology.protein, business, Dyslipidemia
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60871df43dd01a7c43ca9bd3ed8e2362Test
-
4
المؤلفون: Bertrand Cariou, Alexia Letierce, Dirk Müller-Wieland, Lawrence A. Leiter, Marie T. Baccara-Dinet, Rita Samuel
المصدر: Diabetic medicine 35(1), 121-130 (2017). doi:10.1111/dme.13450
Diabetic Medicineمصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, 030204 cardiovascular system & hematology, Gastroenterology, 0302 clinical medicine, Endocrinology, Medicine, 030212 general & internal medicine, Prediabetes, Research Articles, Randomized Controlled Trials as Topic, education.field_of_study, Anticholesteremic Agents, Antibodies, Monoclonal, Research: Treatment, Middle Aged, Treatment Outcome, Female, medicine.drug, Adult, medicine.medical_specialty, Statin, medicine.drug_class, Hypercholesterolemia, Population, Antibodies, Monoclonal, Humanized, Placebo, Prediabetic State, 03 medical and health sciences, Double-Blind Method, Ezetimibe, Internal medicine, Diabetes mellitus, Internal Medicine, Humans, education, Triglycerides, Aged, Alirocumab, Glycated Hemoglobin, business.industry, PCSK9, Cholesterol, LDL, medicine.disease, Treatment, Clinical Trials, Phase III as Topic, Case-Control Studies, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96a66b0612eb40ed576e9c9e9ebba4eTest
https://doi.org/10.1111/dme.13450Test -
5
المؤلفون: Jonas Mandel, Lawrence A. Leiter, Rita Samuel, Dirk Müller-Wieland, Maja Bujas-Bobanovic, Stefano Del Prato, Alexia Letierce, Kausik K. Ray, Bertrand Cariou, Francisco J. Tinahones, Catherine Domenger, Helen M. Colhoun
المصدر: Ray, K K, Del Prato, S, Müller-Wieland, D, Cariou, B, Colhoun, H M, Tinahones, F J, Domenger, C, Letierce, A, Mandel, J, Samuel, R, Bujas-Bobanovic, M & Leiter, L A 2019, ' Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease : analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies ', Cardiovascular diabetology, vol. 18, no. 1, pp. 149 . https://doi.org/10.1186/s12933-019-0951-9Test
Cardiovascular Diabetology
Cardiovascular diabetology 18, 149 (2019). doi:10.1186/s12933-019-0951-9
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-10 (2019)مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, Cardiac & Cardiovascular Systems, Endocrinology, Diabetes and Metabolism, Coronary Disease, Type 2 diabetes, Clinical Trials, Phase IV as Topic, chemistry.chemical_compound, Risk Factors, Multicenter Studies as Topic, 1102 Cardiorespiratory Medicine and Haematology, Randomized Controlled Trials as Topic, Original Investigation, RISK, Anticholesteremic Agents, PCSK9 Inhibitors, Treatment Outcome, SAFETY, Drug Therapy, Combination, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, medicine.medical_specialty, Statin, Serine Proteinase Inhibitors, medicine.drug_class, Placebo, Antibodies, Monoclonal, Humanized, Endocrinology & Metabolism, Internal medicine, Diabetes mellitus, Type 2 diabetes mellitus, medicine, Humans, Low-density lipoprotein cholesterol, ddc:610, Alirocumab, Dyslipidemias, Science & Technology, Cholesterol, business.industry, PCSK9, Cholesterol, HDL, nutritional and metabolic diseases, Cholesterol, LDL, medicine.disease, Atherosclerosis, EFFICACY, chemistry, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Cardiovascular System & Hematology, Dyslipidemia, lcsh:RC666-701, Atherosclerotic cardiovascular disease, Cardiovascular System & Cardiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Biomarkers
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d3a05dee250a4541416b551ab40c13Test
http://hdl.handle.net/11568/1029810Test -
6
المؤلفون: Peter B. Jones, Rita Samuel, Alexia Letierce, Francisco J. Tinahones, Lawrence A. Leiter, Dean G. Karalis, Jonas Mandel, Maja Bujas-Bobanovic
المصدر: Diabetic Medicine
مصطلحات موضوعية: Male, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Heart Diseases, Endocrinology, Diabetes and Metabolism, Hypercholesterolemia, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, Diabetes Complications, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Clinical Trials, Phase II as Topic, Ezetimibe, Diabetes mellitus, Internal medicine, Internal Medicine, Diabetes Mellitus, Medicine, Humans, Adverse effect, Research Articles, Alirocumab, Aged, Randomized Controlled Trials as Topic, business.industry, Proportional hazards model, PCSK9, Incidence, Hazard ratio, PCSK9 Inhibitors, Antibodies, Monoclonal, Research: Treatment, Middle Aged, medicine.disease, Treatment, Clinical Trials, Phase III as Topic, Female, Proprotein Convertase 9, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e4afea874ab351a52f408aadd3c367Test
https://pubmed.ncbi.nlm.nih.gov/30183102Test -
7
المؤلفون: Maciej Banach, Jose Lopez-Sendon, Gregory Bigot, Rita Samuel, Maurizio Averna, Alexia Letierce, Patrick Henry, Megan Loy, Daniel Gaudet, Isabela Batsu
المصدر: Journal of the American College of Cardiology. 75:1958
مصطلحات موضوعية: medicine.medical_specialty, Statin, business.industry, medicine.drug_class, nutritional and metabolic diseases, Familial hypercholesterolemia, medicine.disease, Real life setting, Internal medicine, Medicine, lipids (amino acids, peptides, and proteins), In patient, Lipid lowering, Cardiology and Cardiovascular Medicine, business, Lipoprotein cholesterol, Alirocumab
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d7252a14d94206f7fbfaaa30c4823442Test
https://doi.org/10.1016/s0735-1097Test(20)32585-7 -
8
المؤلفون: Daniel Gaudet, D. Chibedi-De-Roche, Patrick Henry, S. Saubadu, Kurt Huber, Maurizio Averna, Bertrand Cariou, K. Kralova, Richard Ceska, A. Mertens, D. Drouot, Jose Lopez-Sendon, Rita Samuel
المصدر: European Heart Journal. 38
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Internal medicine, Interim, medicine, LDL Cholesterol Lipoproteins, Cardiology and Cardiovascular Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::718fd8adc8fa7209d2a4c5df304af159Test
https://doi.org/10.1093/eurheartj/ehx502.p1502Test -
9
المؤلفون: Rita Samuel, Bertrand Cariou, Stefano Del Prato, Helen M. Colhoun, Jonas Mandel, Catherine Domenger, Dirk Müller-Wieland, Francisco J. Tinahones, Robert R. Henry, Lawrence A. Leiter, Maja Bujas-Bobanovic, Kausik K. Ray
المصدر: Diabetes, Obesity & Metabolism
Leiter, L A, Cariou, B, Müller-Wieland, D, Colhoun, H M, Del Prato, S, Tinahones, F J, Ray, K K, Bujas-Bobanovic, M, Domenger, C, Mandel, J, Samuel, R & Henry, R R 2017, ' Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial ', Diabetes, Obesity and Metabolism . https://doi.org/10.1111/dom.13114Test
Diabetes, obesity and metabolism 19(12), 1781-1792 (2017). doi:10.1111/dom.13114مصطلحات موضوعية: Male, Diabetic Cardiomyopathies, type 1 diabetes, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, lipid‐lowering therapy, Drug Resistance, Type 2 diabetes, 030204 cardiovascular system & hematology, Gastroenterology, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, cardiovascular disease, Insulin, Aged, 80 and over, education.field_of_study, lipid-lowering therapy, Anticholesteremic Agents, Antibodies, Monoclonal, clinical trial, Middle Aged, Diabetes and Metabolism, Cardiovascular Diseases, Female, Original Article, lipids (amino acids, peptides, and proteins), type 2 diabetes, Risk, medicine.medical_specialty, Injections, Subcutaneous, Hypercholesterolemia, Population, 030209 endocrinology & metabolism, Antibodies, Monoclonal, Humanized, Placebo, Drug Administration Schedule, Endocrinology & Metabolism, 03 medical and health sciences, Double-Blind Method, Internal medicine, Diabetes mellitus, Journal Article, Internal Medicine, medicine, Humans, Hypoglycemic Agents, ddc:610, education, Aged, Alirocumab, Type 1 diabetes, Cholesterol, business.industry, 1103 Clinical Sciences, Original Articles, medicine.disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, chemistry, Physical therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Diabetic Angiopathies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028448b69fbf7c684307733659db8c1fTest
-
10
المؤلفون: Helen M. Colhoun, Stefano Del Prato, Rita Samuel, Lawrence A. Leiter, Dirk Müller-Wieland, Catherine Domenger, Jonas Mandel, Francisco J. Tinahones, Alexia Letierce, Bertrand Cariou, Maja Bujas-Bobanovic, Robert R. Henry, Kausik K. Ray
المصدر: Atherosclerosis Supplements. 32:152-153
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Insulin, medicine.medical_treatment, General Medicine, medicine.disease, Add on therapy, Internal medicine, Internal Medicine, medicine, Cardiology and Cardiovascular Medicine, business, Dyslipidemia, Alirocumab
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6e04e2d09689634bb8f4dd48bcc4ec47Test
https://doi.org/10.1016/j.atherosclerosissup.2018.04.465Test